Isaac Francis

Telegram reported operating revenue of $870 million in the first half of 2025, marking a 65% increase from $525 million a year earlier, according to the Financial Times.

Stereotaxis (NYSE:STXS), a global leader in endovascular surgical robotics, announced on Tuesday, January 6, 2026, that it has received U.S. Food and Drug Administration (FDA) approval for its MAGiC™ Magnetic Interventional Ablation Catheter.

Profound Medical Corp. (NASDAQ:PROF) on Tuesday announced that Johns Hopkins Hospital has performed its first commercial prostate cancer treatment using the company's TULSA-PRO system, marking a key adoption milestone for the MRI-guided, incision-free ablation technology.

Lithium Argentina AG (NYSE:LAR) shares are in focus after the company announced standout preliminary 2025 results for its Cauchari-Olaroz operation.

The project, a joint venture with Ganfeng Lithium, achieved full-year production of 34,100 tonnes of lithium carbonate—reaching the upper limit of its 30,000–35,000 tonne guidance.

AngioDynamics (NASDAQ:ANGO) on Tuesday reported fiscal second-quarter results that highlighted continued momentum in its high-margin Med Tech portfolio, with overall net sales rising 8.8% year over year to $79.4 million for the period ended Nov. 30, 2025.

Hyundai plans to roll out human-like robots across its factories as global manufacturers race to adopt automation.

Chrystia Freeland is leaving Canada’s parliament to take on an advisory role with Ukraine’s president.

South Korea’s president has sought to reset relations with China during a rare state visit to Beijing.

US regulators have cut the list of vaccines routinely recommended for all children, citing international comparisons and public trust concerns.

Starknet entered 2026 with fresh mainnet downtime as the team worked to restore network functionality.